What is the appropriate digoxin dosing regimen for adults, including loading and maintenance doses, and how should it be adjusted for elderly patients or those with impaired renal function?

Digoxin Dosing in Adults

For adults under 70 years with normal renal function, initiate digoxin at 0.25 mg daily; for those over 70 or with impaired renal function, start at 0.125 mg daily; and for patients with marked renal impairment, begin at 0.0625 mg daily, targeting serum concentrations of 0.5–0.9 ng/mL to minimize mortality risk while maintaining efficacy. 1

Initial Dosing Strategy

Standard Maintenance Dosing (Preferred Approach)

• Begin with maintenance dosing rather than loading doses for chronic heart failure, allowing digoxin body stores to accumulate gradually over 1–3 weeks (approximately five half-lives). 1

• Adults <70 years with good renal function: Start 0.25 mg once daily 1

• Adults ≥70 years or impaired renal function: Start 0.125 mg once daily 1

• Marked renal impairment: Start 0.0625 mg once daily 1

• Doses may be increased every 2 weeks based on clinical response. 1

Rapid Digitalization with Loading Dose (When Medically Appropriate)

• Total loading dose: 750–1250 mcg (0.75–1.25 mg) for a 70 kg patient to achieve peak body stores of 8–12 mcg/kg 1

• Administration protocol: Give approximately half the total dose initially, then additional fractions of 125–375 mcg at 6–8 hour intervals with careful clinical assessment before each dose 1

• Initial dose produces detectable effect in 0.5–2 hours, maximal effect in 2–6 hours 1

• Critical caveat for renal insufficiency: Patients with impaired renal function should receive conservative loading doses targeting 6–10 mcg/kg (rather than 8–12 mcg/kg) due to altered distribution and elimination 1

• Specific loading dose reduction for renal dysfunction: Patients with creatinine clearance <60 mL/min require reduced loading doses of 6–10 mcg/kg, as they are significantly more likely to experience toxic concentrations with standard loading strategies 2

Maintenance Dose Calculation Based on Renal Function

Formula-Based Approach

• Maintenance Dose = Peak Body Stores × % Daily Loss/100 1

• % Daily Loss = 14 + (Creatinine Clearance/5) 1

• Creatinine clearance should be corrected to 70 kg body weight or 1.73 m² body surface area 1

Practical Dosing Table by Weight and Renal Function

For a 70 kg patient with estimated peak body stores of 10 mcg/kg: 1

• CrCl 10 mL/min: 125 mcg daily (steady-state in ~19 days)
• CrCl 20 mL/min: 125 mcg daily (steady-state in ~16 days)
• CrCl 30 mL/min: 187.5 mcg daily (steady-state in ~14 days)
• CrCl 40 mL/min: 187.5 mcg daily (steady-state in ~13 days)
• CrCl 50 mL/min: 187.5 mcg daily (steady-state in ~12 days)
• CrCl 60 mL/min: 250 mcg daily (steady-state in ~11 days)
• CrCl 70 mL/min: 250 mcg daily (steady-state in ~10 days)
• CrCl 80 mL/min: 250 mcg daily (steady-state in ~9 days)
• CrCl 90 mL/min: 250 mcg daily (steady-state in ~8 days)
• CrCl 100 mL/min: 250 mcg daily (steady-state in ~7 days)

Special Populations

Elderly Patients (≥70 Years)

• Lower doses are mandatory due to age-related decline in renal function even when serum creatinine appears normal 1

• Recommended doses: 62.5–125 mcg daily for most elderly patients with eGFR <60 mL/min/1.73 m² 3

• Target serum concentration: 0.5–0.9 ng/mL (lower than historical ranges) 4

Severe Renal Impairment (CrCl <30 mL/min)

• Maintenance doses: 62.5 mcg daily or even lower (31.25 mcg daily) may be required 3

• Loading doses: Should be reduced to 6–10 mcg/kg if used at all 2

• Volume of distribution is reduced by approximately one-third in dialysis-dependent patients, necessitating lower loading doses around 10 mcg/kg 5

Patients on Amiodarone

• N-desethylamiodarone (amiodarone metabolite) significantly reduces digoxin clearance 6

• Recommended dose with amiodarone: 0.0625 mg daily for patients with CrCl >30 mL/min 6

• For CrCl ≤30 mL/min and N-desethylamiodarone >600 ng/mL: Consider 0.03125 mg daily due to markedly reduced digoxin clearance 6

• Digoxin clearance decreases by 3% for every 100 ng/mL increase in N-desethylamiodarone concentration 6

Target Serum Concentrations

Optimal Therapeutic Range

• Target: 0.5–0.9 ng/mL for heart failure and atrial fibrillation 4

• Concentrations >1.0 ng/mL are associated with increased mortality without additional clinical benefit 4

• Overt toxicity typically occurs at >2.0 ng/mL, though toxicity can manifest at lower levels with electrolyte disturbances 4

• Historical ranges of 0.8–2.0 ng/mL are outdated and associated with worse outcomes 4

When to Measure Digoxin Levels

Do NOT perform routine monitoring—it does not improve outcomes 4

Measure levels only when: 4

• Digoxin toxicity is suspected (confusion, nausea, visual disturbances, arrhythmias)
• New interacting drugs are started (amiodarone, verapamil, quinidine, macrolides, dronedarone, itraconazole, propafenone)
• Significant decline in renal function occurs
• Electrolyte abnormalities are present (hypokalemia, hypomagnesemia, hypercalcemia)

Timing of Blood Sampling

• Sample just before the next scheduled dose (trough level) 1

• If not possible, wait at least 6–8 hours after the last dose regardless of route or formulation 1

• On once-daily dosing: Concentration will be 10–25% lower at 24 hours versus 8 hours post-dose, depending on renal function 1

Mandatory Concurrent Monitoring

Essential Laboratory Parameters

• Monitor serum potassium regularly—hypokalemia heightens myocardial sensitivity to digoxin even at therapeutic concentrations 4

• Monitor serum creatinine/creatinine clearance—renal function determines digoxin elimination 4

• Monitor serum magnesium—hypomagnesemia increases toxicity risk 4

• Frequency should be tailored to clinical stability and concurrent medications (diuretics, ACE inhibitors, ARBs) 4

Critical Pitfalls to Avoid

• Do not use routine digoxin level monitoring—evidence shows no outcome benefit 4

• Do not overlook electrolyte abnormalities—toxicity occurs at "therapeutic" digoxin levels when potassium or magnesium are low 4

• Do not rely on outdated therapeutic ranges (0.8–2.0 ng/mL)—these are associated with increased mortality 4

• Do not forget drug-drug interactions—many cardiac medications (especially amiodarone) markedly raise digoxin levels 4, 6

• Do not use standard loading doses in renal impairment—patients with CrCl <60 mL/min have significantly higher risk of toxic concentrations 2

• Do not calculate doses based on total body weight—use lean (ideal) body weight 1

• Do not administer high doses (>0.25 mg daily) for rate control in atrial fibrillation—add beta-blockers or amiodarone instead (and reduce digoxin dose if amiodarone is added) 7